Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer

Technology appraisal guidance
Reference number: TA263
Published: 22 August 2012

Information for the public

Bevacizumab with capecitabine as first-line treatment for metastatic breast cancer (PDF 180 KB)

Published:

22 August 2012
Gwybodaeth i'r cyhoedd (Word 158 KB)

Published:

15 October 2012